Global efforts to combat tuberculosis (TB) are progressing, with promising developments in drug-resistant prevention and tuberculosis diagnostics. The World Health Organization (WHO) expresses optimism about eradicating TB, while the United Nations aims to reduce TB-related deaths by 75% by 2025. Co-Diagnostics, Inc. receives a $8.976 million grant from the Bill Melinda Gates Foundation to support the development of a tuberculosis test for its Co-Dx PCR platform. The global tuberculosis diagnostics market is projected to reach USD 3.19 billion by 2030.

Global Tuberculosis Initiatives